THE ESTIMATION OF PHARMACOKINETIC PARAMETERS AND ACCURACY OF THE PREDICTED EQUATION FOR LITHIUM DOSE IN CHILDREN: A PILOT STUDY AT THE YUWAPRASART WAITHAYOPATHUM CHILD PSYCHIATRIC HOSPITAL
Objective: The purpose of the study was to estimate the pharmacokinetic parameters and calculate the precision (%RMSE) of the predicted lithium concentration equation.
Methods: This research was studied from blood Lithium levels of Children who had visited Yuwaprasart Waithayopathum Child Psychiatric Hospital from 31 December 2009-1 January 2011 The accuracy and precision of the equation were evaluated by the mathematical principle. The assist package software (WIN-NONLIN) was used to create pharmacokinetic parameters.
Results: Twenty-nine patients were recruited. The characteristics (mean+SD) presented as the following; age = 15.79+2.64 y, weight = 69.75+22.28 kg and the daily dose = 858.62+274.53 mg. The trough Lithium concentrations (mean+SD) = 0.56+19 mg/l. The kinetic parameter (Mean+SD) presented as the following; t1/2 =7.23+3.38 hr., ke =0.12+0.07 hr-1, Vd = 48.83+15.60 L, AUC0-12 =11.01+5.61 mg x hr/l. The population pharmacokinetic parameters; ke, and AUC (0-âˆž) = 0.151 hr-1 and 169.81, mg x hr./l respectively. The modified equation from Yukawa for lithium clearance calculation and prediction lithium concentrations were CL (mL/min) = [36.5+(0.242x BW (kg)-7.79]/Scr (mg/dL) and lithium concentration (mg/l) = 4 x Dose (mg)/CL (mL/min)x73.89, respectively with 6.39 %RMSE (test for 20 patients data).
Conclusion: In conclusion, the modified Yukawa equation may be used for the prediction of lithium concentration with 6.39% RMSE.
2. Lopez Larson M, Frazier JA. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders. Harv Rev Psychiatry 2006;14:285-304.
3. Masi G, Milone A, Manfredi A, Pari C, Paziente A, Millepiedi S. Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study. CNS Drugs 2009;23:59-69.
4. Micromedex, Lithium. Thomson Health care; 2012.
5. Bramness JG, GrÃ¸holt B, Engeland A, Furu K. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-a prescription database study. J Affect Disord 2009;117:208-11.
6. Harvard Medical School. Lithium-induced kidney problems. Serious problems are unusual, but monitoring is key. Harv Ment Health Lett 2009;26:6-7.
7. Grandjean EM, JM Aubry. Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring. CNS Drugs 2009;23:331-49.
8. Sharma S, S Joshi, RK Chadda. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India. Am J Ther 2009;16:393-7.
9. Reischer H, CR Pfeffer. Lithium pharmacokinetics. J Am Acad Child Adolesc Psychiatry 1996;35:130-1.
10. Arancibia A. Pharmacokinetics of lithium in healthy volunteers after exposure to high altitude. Int J Clin Pharmacol Ther 2003;41:200-6.
11. Chen KP, WW Shen, ML Lu. Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry Clin Neurosci 2004;58:25-9.
12. Lewis AM. Monitoring patients on lithium in the primary care setting. Nurs Times 2004;100:35.
13. Ratanajamit C, Soorapan S, Doang-Ngern T, Waenwaisart W, Suwanchavalit L, Suwansiri S, et al. Appropriateness of therapeutic drug monitoring for lithium. J Med Assoc Thai 2006;89:1954-60.
14. Motoki T. Calculation of lithium clearance for clinical use based on renal excretion in Japanese patients. Int J Clin Pharmacol Pharmacother 2016;1:107.
15. Abou Auda HS, Al Yamani MJ, Abou Shaaban RR, Khoshhal SI. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients. Bipolar Disord 2008;10:369-76.
16. ElDesoky ES, Kumar V, Alorainy MS, Hamdi MM, Derendorf H. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach. Int J Clin Pharmacol Ther 2008;46:617-26.
17. Findling RL, Landersdorfer CB, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, et al. First-dose pharmacokinetics of lithium carbonate in children and adolescents. J Clin Psychopharmacol 2010;30:404-10.
18. Huang HC, Chang YL, Lan TH, Chiu HJ, Liu WM, Lee TJ. Prediction of optimal litium dose for Taiwanese psychiatric patients. J Can Pet Technol 2008;33:115-21.
19. Higuchi S, Fukuoka R, Aoyama T, Horioka M. Predicting serum lithium concentration using bayesian method: a comparison with other methods. J Pharmacobiodyn 1988;11:158-74.
20. Jermain DM, ML Crismon, ES Martin. 3rd. Population pharmacokinetics of lithium. Clin Pharm 1991;10:376-81.
21. Kerbusch T, Mathot RA, Otten HM, Meesters EW, Van Kan HJ, Schellens JH, et al. Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent hemodialysis: a case report. Pharmacol Toxicol 2002;90:243-5.
22. Pumpaisarnchai W, Kittirattanapaiboon P, Sanichwannakul K. A simple mathematical model for prediction lithium maintenance dose requirement for individual Thai patents. [Research Report], Changmai; Suan prung psychiatric hospital; 1996.
23. Schou M, K Thomsen, P Vestergaard. The renal lithium clearance and its correlations with other biological variables: observations in a large group of physically healthy persons. Clin Nephrol 1986;25:207-11.
24. Smith EG. Lithium dosing schedule and renal insufficiency. J Clin Psychiatry 2005;66:396-7.
25. Sproule BA, Bazoon M, Shulman KI, Turksen IB, Naranjo CA. Fuzzy logic pharmacokinetic modeling: application to lithium concentration prediction. Clin Pharmacol Ther 1997;62:29-40.
26. Suwan P. Prediction of steady-state serum lithium concentration by population model, [Thesis] in the pharmacy department. Faculty of Pharmacy, Silpakorn University: Meaung Nakhon Pathom, Thailand; 2009.
27. Taright N, Mentre F, Mallet A, Jouvent R. Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach. Ther Drug Monit 1994;16:258-69.
28. Tyrer SP, Grof P, Kalvar M, Shopsin B. Estimation of lithium dose requirement by lithium clearance, serum lithium and saliva lithium following a loading dose of lithium carbonate. Neuropsychobiology 1981;7:152-8.
29. Nichols TA, Drayton SJ, Borckardt J, Taber DJ. Lithium dosing equations: are they accurate? Ann Pharmacother 2014;48:596â€“600.
30. Williams PJ, JL Browne, RA Patel. Bayesian forecasting of serum lithium concentrations. Comparison with traditional methods. Clin Pharmacokinet 1989;17:45-52.
31. Wing YK1, Chan E, Chan K, Lee S, Shek CC. Lithium pharmacokinetics in Chinese manic-depressive patients. J Clin Psychopharmacol 1997;17:179-84.
32. Yukawa E, Nomiyama N, Higuchi S, Aoyama T. Lithium population pharmacokinetics from routine clinical data: the role of patient characteristics for estimating dosing regimens. Ther Drug Monit 1993;15:75-82.
33. Cornelia B. Lithium in pediatric patients with bipolar disorder: implications for selection of dosage regimens via population pharmacokinetics/pharmacodynamics. Clin Pharmacokinet 2017;56:77-90.